Patent directory · USPTO A61K / A61P
Patents matching “tablet”
48 pharma patents match "tablet" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 48 pharmaceutical patents matching "tablet" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12318487
Solid tablet dosage form of ridinilazole
granted -
US 12208167
Coated tablets for pH-dependent release of benzgalantamine
granted -
US 12048691
High dosage tebipenem pivoxil tablet formulation
granted -
US 2022354866
IMMEDIATE RELEASE MULTILAYER TABLET
granted -
US 11253445
Oxidative hair color remover in tablet or pellet form
granted -
US 10835541
Tablet
granted -
US 10668021
Metformin hydrochloride osmotic pump tablet and preparation method therefor
granted -
EP 3539539
TABLETTENFORMULIERUNGEN AUS (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLIN-1,3-DION
granted -
US 10238605
Dry coated tablet
granted -
US 10004691
Orally disintegrable tablet
granted -
US 9999634
Dissolution stability of calcium carbonate tablets
granted -
US 9901546
Orally disintegrable tablets
granted -
US 9693962
Dry-coated tablet
granted -
US 9433632
Dry coated tablet
granted -
US 9326946
Laminated tablet and manufacturing method therefor
granted -
US 9320714
Tablet
granted -
US 9295659
High dose extended-release potassium citrate wax matrix tablet
granted -
US 9205032
Pressed tablet tissue application box
granted -
US 9180198
Slow-release cilostazol tablet having an improved elution rate and minimal side effects
granted -
US 9101565
Dissolution stability of calcium carbonate tablets
granted -
US 8920840
Enteric tablet
granted -
US 8906949
Orally disintegrating tablets of zolmitriptan and process for preparing the same
granted -
US 8821926
Tablet containing hardly soluble active ingredient
granted -
US 8765176
Method of manufacturing tablet
granted